Related references
Note: Only part of the references are listed.Screening of potential a, disintegrin and metalloproteinase with thrombospondin motifs-4 inhibitors using a collagen model fluorescence resonance energy transfer substrate
Janelle L. Lauer-Fields et al.
ANALYTICAL BIOCHEMISTRY (2008)
Reappraising metalloproteinases in rheumatoid arthritis and osteoarthritis: destruction or repair?
Gillian Murphy et al.
NATURE CLINICAL PRACTICE RHEUMATOLOGY (2008)
Functional differences of the catalytic and non-catalytic domains in human ADAMTS-4 and ADAMTS-5 in aggrecanolytic activity
Kazunari Fushimi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
5'-Phenyl-3'H-spiro[indoline-3,2'-[1,3,4]thiadiazol]-2-one inhibitors of ADAMTS-5 (Aggrecanase-2)
Matthew G. Bursavich et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2007)
TIMP-3 inhibition of ADAMTS-4 (Aggrecanase-1) is modulated by interactions between aggrecan and the C-terminal domain of ADAMTS-4
Gareth J. Wayne et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Proteolytic activities of human ADAMTS-5 - Comparative studies with ADAMTS-4
Christi Gendron et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Synthesis and evaluation of aryl thioxothiazolidinone inhibitors of ADAMTS-5 (Aggrecanase-2)
Matthew G. Bursavich et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2007)
Aggrecan degradation in human articular cartilage explants is mediated by both ADAMTS-4 and ADAMTS-5
Ruo-Hua Song et al.
ARTHRITIS AND RHEUMATISM (2007)
Increased collagen and aggrecan degradation with age in the joints of Timp3-/- mice
Solmaz Sahebjam et al.
ARTHRITIS AND RHEUMATISM (2007)
TIMP-3 inhibits the procollagen N-proteinase ADAMTS-2
Wei-Man Wang et al.
BIOCHEMICAL JOURNAL (2006)
Structure and function of matrix metalloproteinases and TIMPs
H Nagase et al.
CARDIOVASCULAR RESEARCH (2006)
Human osteoarthritis synovial fluid and joint cartilage contain both aggrecanase- and matrix metalloproteinase-generated aggrecan fragments
A Struglics et al.
OSTEOARTHRITIS AND CARTILAGE (2006)
Effects of pentosan polysulfate in osteoarthritis of the knee: a randomized, double-blind, placebo-controlled pilot study
P Ghosh et al.
CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL (2005)
Deletion of active ADAMTS5 prevents cartilage degradation in a murine model of osteoarthritis
SS Glasson et al.
NATURE (2005)
ADAMTS5 is the major aggrecanase in mouse cartilage in vivo and in vitro
H Stanton et al.
NATURE (2005)
ADAMTS4 (aggrecanase-1) activation on the cell surface involves C-terminal cleavage by glycosylphosphatidyl inositol-anchored membrane type 4-matrix metalloproteinase and binding of the activated proteinase to chondroitin sulfate and heparan sulfate on syndecan-1
G Gao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Altered proteolytic activities of ADAMTS-4 expressed by C-terminal processing
M Kashiwagi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Low density lipoprotein receptor-related protein mediates endocytic clearance of Pro-MMP-2•TIMP-2 complex through a thrombospondin-independent mechanism
H Emonard et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
TIMP-3 inhibits aggrecanase-mediated glycosaminoglycan release from cartilage explants stimulated by catabolic factors
C Gendron et al.
FEBS LETTERS (2003)
Expression of mutant and wild-type TIMP3 in primary gingival fibroblasts from Sorsby's fundus dystrophy patients
CE Arris et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2003)
Autocatalytic cleavage of ADAMTS-4 (Aggrecanase-1) reveals multiple glycosaminoglycan-binding sites
CR Flannery et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Activation of the proteolytic activity of ADAMTS4 (Aggrecanase-1) by C-terminal truncation
G Gao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
LRP: a multifunctional scavenger and signaling receptor
J Herz et al.
JOURNAL OF CLINICAL INVESTIGATION (2001)
TIMP-3 is a potent inhibitor of aggrecanase 1 (ADAM-TS4) and aggrecanase 2 (ADAM-TS5)
M Kashiwagi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Critical appraisal of the use of matrix metalloproteinase inhibitors in cancer treatment
S Zucker et al.
ONCOGENE (2000)
TIMP-3 binds to sulfated glycosaminoglycans of the extracellular matrix
WH Yu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Conformational changes in serpins: II. The mechanism of activation of antithrombin by heparin
JC Whisstock et al.
JOURNAL OF MOLECULAR BIOLOGY (2000)